Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Very Brief Exposure: Development of a Novel Exposure Modality for Social Anxiety Disorder in Transition-Age Youth

A legfontosabb adatok

Ki végzi
Children's Hospital Los Angeles
Hol
Los Angeles (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
120 fő vett részt
Kezdés
2024. aug. 14.
Befejezés
2026. okt. 26.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • Very Brief Exposure to Facial Expressions
A regiszteradat frissítve
2026. október 28.

Ki vehet részt

Életkor
16 év – 22 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 6 feltétel megnézéseKevesebb

Ki vehet részt

  • Patient Population; Males and females aged 16-22. This age range corresponds with our prior studies of very brief exposure (VBE) in Specific Phobia and will include older adolescents while minimizing potential developmental effects on circuit activation; Youth with a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of Social Anxiety Disorder (SAD) on Kiddie Schedule for Affective Disorders and Schizophrenia for School-Aged Children, Computerized version (K-SADS-COMP) for youth ages 16-17, or the computerized version of Structured Clinical Interview for the DSM-5 (NetSCID) for youth ages 18+
  • Healthy Population; Male and female youth aged 16-22
  • Parents • Parent/caregiver of all ages, no restrictions who are fluent in either English or Spanish

Ki nem vehet részt

  • Patient Population; Primary language other than English or Spanish; Active suicidality on the Colombia-Suicide Severity Scale (plan, intent, or behavior); Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make-up with metallic content, transdermal medicinal patches that cannot be removed; Current psychoactive medication; Lifetime diagnosis of: obsessive-compulsive disorder (OCD), psychotic, bipolar, autism spectrum disorder, intellectual disability on the KSADS-COMP or NetSCID; Any serious neurological or medical conditions (e.g., Lupus, cancer, human immunodeficiency virus positive (HIV+)) as reported by potential participants; Current Post-Traumatic Stress Disorder (PTSD) diagnosis; Current severe substance abuse (except tobacco/nicotine); Pregnancy, as determined by the participant's self-report prior to the magnetic resonance imaging (MRI) scan
  • Healthy Population; Primary language other than English or Spanish; Lifetime disorders: any anxiety disorders, OCD, psychotic, bipolar, autism spectrum disorder, intellectual disability; any psychiatric disorder in the past 2 years; Current depression disorder; Active psychiatric disorder in the past 2 years; Serious neurological or medical conditions; Current psychoactive medication; Ferromagnetic implants (e.g., pacemaker), metal braces, retainers, tattoos or permanent make-up with metallic content, transdermal medicinal patches that cannot be removed; Active suicidality on the Colombia-Suicide Severity Scale (plan, intent, or behavior); Pregnancy, as determined by the participant's self-report prior to the MRI scan
  • Parents • Primary language other than English or Spanish

Helyszínek itt: Egyesült Államok

  • Children's Hospital Los AngelesLos Angeles, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE on subjective fear ratings, and participants' awareness and tolerance of the exposure stimuli.

A teljes eredeti leírásKevesebb

* The primary outcome of this study is the mean activation of frontostriatal and prefrontal brain regions to facial stimuli, as measured by Blood Oxygen Level Dependent (BOLD) response, in 4 regions of interest during the magnetic resonance imaging (MRI). * Another primary outcome of the study is to identify networks of regions subserving emotion regulation and attention, as measured by BOLD response of corresponding brain regions.

Secondary Outcomes

-The secondary outcome of this study is the fear induced by exposure to facial expression stimuli as measured by a 4-point fear scale during the functional magnetic resonance imaging (fMRI) after each block of 10 facial expression stimuli trials.

Participants will participate in an interview where they will answer questions both inside and outside of the MRI scan. Participants will be asked to rate on a scale the imagines they see while undergoing MRI scan.

A vizsgálat csoportja

  • Image Exposure ArmA vizsgált kezelés

    Participants will see various images of facial expressions on a computer screen and provide various rating scores about them.

    Kezelés: Very Brief Exposure to Facial Expressions

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. október 28.